Your browser doesn't support javascript.
loading
Inappropriate prescriptions of direct oral anticoagulants (DOACs) in hospitalized patients: A narrative review.
van der Horst, S F B; van Rein, N; van Mens, T E; Huisman, M V; Klok, F A.
Affiliation
  • van der Horst SFB; Department of Medicine - Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, Netherlands. Electronic address: s.f.b.van_der_horst@lumc.nl.
  • van Rein N; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, Netherlands.
  • van Mens TE; Department of Medicine - Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, Netherlands; Amsterdam UMC, Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam Reproduction and Development, University of Amsterdam, Amsterdam, Netherlands.
  • Huisman MV; Department of Medicine - Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, Netherlands.
  • Klok FA; Department of Medicine - Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, Netherlands.
Thromb Res ; 231: 135-140, 2023 11.
Article in En | MEDLINE | ID: mdl-37005194
ABSTRACT
Direct oral anticoagulants (DOACs) have become the cornerstone for prevention of thromboembolic events in patients with atrial fibrillation and patients with a history of venous thromboembolism. However, studies show that DOAC prescriptions are commonly inconsistent with guideline recommendations. DOAC dosing in the acutely ill patient could impose an even greater challenge. In this review, we describe the prevalence of inappropriate inpatient prescribing of DOACs and the associated rationales, predictors and clinical consequences. With the aim of promoting appropriate prescriptions of DOACs to hospitalized patients, we further outline DOAC dose reduction criteria justified by various guidelines, illustrating the complexities of appropriate dosing, especially in acutely ill patients. Moreover, we will discuss the impact of anticoagulant stewardship programs and the vital role that pharmacists may play in optimizing inpatient DOAC treatment.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Stroke / Venous Thromboembolism Type of study: Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Thromb Res Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Stroke / Venous Thromboembolism Type of study: Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Thromb Res Year: 2023 Document type: Article